Philipp Kaldis Selected Research

Philipp Kaldis Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 09/2004
4	Carcinogenesis 07/2014 - 05/2009
2	Obesity 01/2023 - 09/2020
2	Inflammation (Inflammations) 11/2020 - 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Hyperglycemia 01/2023
1	Insulin Resistance 01/2023
1	Cholestasis 01/2021
1	Polyploidy 11/2020
1	Fatty Liver 10/2020
1	Cysts 01/2020
1	Hypertrophy 01/2020
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2020
1	Genomic Instability 01/2019
1	Bone Fractures (Bone Fracture) 12/2018
1	Infertility (Sterility) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 09/2015
1	Retinoblastoma (Glioblastoma, Retinal) 04/2015
1	Glomerulonephritis 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012
1	Tics (Tic) 01/2012
1	Breast Neoplasms (Breast Cancer) 05/2011
1	Melanoma (Melanoma, Malignant) 05/2011
1	Reperfusion Injury 11/2008
1	Ischemia 11/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2008
1	Carney Complex 11/2006

Drug/Important Bio-Agent (IBA)

4	CyclinsIBA 11/2020 - 03/2005
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 05/2009
3	EnzymesIBA 01/2023 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 12/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2008
3	Phosphotransferases (Kinase)IBA 01/2016 - 01/2009
2	CytokinesIBA 11/2020 - 01/2019
2	LipidsIBA 10/2020 - 09/2020
2	Cyclin-Dependent Kinase 2IBA 01/2020 - 11/2008
2	Retinoblastoma ProteinIBA 04/2015 - 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	MethyltransferasesIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	NucleotidesIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 01/2022
1	CarbonIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	bile acid binding proteinsIBA 01/2021
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2020
1	RoscovitineIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	InterleukinsIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Anabolic AgentsIBA 12/2018
1	Poly I-CIBA 09/2015
1	Lysine (L-Lysine)FDA Link 09/2015
1	Sorafenib (BAY 43-9006)FDA Link 09/2015
1	poly ICLCIBA 09/2015
1	Clodronic Acid (Clodronate)IBA 09/2014
1	Cyclin A2IBA 07/2014
1	pyrimidineIBA 01/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2012
1	Serine (L-Serine)FDA Link 01/2012
1	Stem Cell FactorIBA 01/2012
1	Glycine Dehydrogenase (Decarboxylating)IBA 01/2012
1	Cyclin D1IBA 09/2009
1	Cyclin EIBA 05/2009
1	Cyclin DIBA 05/2009
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2006
1	Cyclic AMP (AMP, Cyclic)IBA 11/2006
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 03/2005
1	CCAAT-Enhancer-Binding Protein-betaIBA 09/2004

Therapy/Procedure

9	Therapeutics 01/2019 - 12/2008